Literature DB >> 32764124

Optical Imaging Modalities: Principles and Applications in Preclinical Research and Clinical Settings.

Giacomo Pirovano1, Sheryl Roberts1, Susanne Kossatz2,3,4, Thomas Reiner5,6,7.   

Abstract

With the ability to noninvasively image and monitor molecular processes within tumors, molecular imaging represents a fundamental tool for cancer scientists. In the current review, we describe emergent optical technologies for molecular imaging. We aim to provide the reader with an overview of the fundamental principles on which each imaging strategy is based, to introduce established and future applications, and to provide a rationale for selecting optical technologies for molecular imaging depending on disease location, biology, and anatomy. To accelerate clinical translation of imaging techniques, we also describe examples of practical applications in patients. Elevating these techniques into standard-of-care tools will transform patient stratification, disease monitoring, and response evaluation.
© 2020 by the Society of Nuclear Medicine and Molecular Imaging.

Entities:  

Keywords:  cancer; imaging; optical modalities

Year:  2020        PMID: 32764124     DOI: 10.2967/jnumed.119.238279

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  13 in total

1.  Evaluating the Accuracy of FUCCI Cell Cycle In Vivo Fluorescent Imaging to Assess Tumor Proliferation in Preclinical Oncology Models.

Authors:  Yun Lu; Adriana V F Massicano; Carlos A Gallegos; Katherine A Heinzman; Sean W Parish; Jason M Warram; Anna G Sorace
Journal:  Mol Imaging Biol       Date:  2022-06-01       Impact factor: 3.488

2.  Non-invasive In Vivo Tracking of Mammalian Cells Stably Expressing Firefly Luciferase.

Authors:  Yang Bi; Nannan Zhang; Yun He
Journal:  Methods Mol Biol       Date:  2022

Review 3.  Imaging ligands targeting glypican-3 receptor expression in hepatocellular carcinoma.

Authors:  Shaun D Grega; David X Zheng; Qi-Huang Zheng
Journal:  Am J Nucl Med Mol Imaging       Date:  2022-08-20

Review 4.  Systematic Review: Targeted Molecular Imaging of Angiogenesis and Its Mediators in Rheumatoid Arthritis.

Authors:  Fatemeh Khodadust; Aiarpi Ezdoglian; Maarten M Steinz; Judy R van Beijnum; Gerben J C Zwezerijnen; Gerrit Jansen; Sander W Tas; Conny J van der Laken
Journal:  Int J Mol Sci       Date:  2022-06-25       Impact factor: 6.208

5.  A phase I study of a PARP1-targeted topical fluorophore for the detection of oral cancer.

Authors:  Paula Demétrio de Souza França; Susanne Kossatz; Christian Brand; Daniella Karassawa Zanoni; Sheryl Roberts; Navjot Guru; Dauren Adilbay; Audrey Mauguen; Cristina Valero Mayor; Wolfgang A Weber; Heiko Schöder; Ronald A Ghossein; Ian Ganly; Snehal G Patel; Thomas Reiner
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-05-05       Impact factor: 10.057

Review 6.  A brief review of reporter gene imaging in oncolytic virotherapy and gene therapy.

Authors:  Susanna C Concilio; Stephen J Russell; Kah-Whye Peng
Journal:  Mol Ther Oncolytics       Date:  2021-03-10       Impact factor: 7.200

Review 7.  Recent Trends in Photoacoustic Imaging Techniques for 2D Nanomaterial-Based Phototherapy.

Authors:  Woo Yeup Jeong; Moon Sung Kang; Haeni Lee; Jong Hun Lee; Jeesu Kim; Dong-Wook Han; Ki Su Kim
Journal:  Biomedicines       Date:  2021-01-15

Review 8.  Functionalized Nanomaterials as Tailored Theranostic Agents in Brain Imaging.

Authors:  Ramar Thangam; Ramasamy Paulmurugan; Heemin Kang
Journal:  Nanomaterials (Basel)       Date:  2021-12-22       Impact factor: 5.076

Review 9.  Metal-Organic Frameworks and Their Composites Towards Biomedical Applications.

Authors:  Yana Ma; Xianglong Qu; Cui Liu; Qiuran Xu; Kangsheng Tu
Journal:  Front Mol Biosci       Date:  2021-12-21

Review 10.  Preclinical Imaging Evaluation of miRNAs' Delivery and Effects in Breast Cancer Mouse Models: A Systematic Review.

Authors:  Francesca Maria Orlandella; Luigi Auletta; Adelaide Greco; Antonella Zannetti; Giuliana Salvatore
Journal:  Cancers (Basel)       Date:  2021-11-30       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.